151 related articles for article (PubMed ID: 18622269)
1. Promises and obstacles for the blockade of CD40-CD40L interactions in allotransplantation.
Li XL; Ménoret S; Le Mauff B; Angin M; Anegon I
Transplantation; 2008 Jul; 86(1):10-5. PubMed ID: 18622269
[TBL] [Abstract][Full Text] [Related]
2. The CD40/CD40L system: a new therapeutic target for disease.
Zhang B; Wu T; Chen M; Zhou Y; Yi D; Guo R
Immunol Lett; 2013 Jun; 153(1-2):58-61. PubMed ID: 23892087
[TBL] [Abstract][Full Text] [Related]
3. Generation and characterization of a novel anti-rat CD40L antibody with inhibitory activities in vitro and in vivo.
Stax AM; Gelderman KA; Kamerling SW; van der Geest R; Schlagwein N; van Kooten C
J Immunol Methods; 2008 Jun; 335(1-2):46-52. PubMed ID: 18384807
[TBL] [Abstract][Full Text] [Related]
4. Blockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse.
Komura K; Fujimoto M; Yanaba K; Matsushita T; Matsushita Y; Horikawa M; Ogawa F; Shimizu K; Hasegawa M; Takehara K; Sato S
Ann Rheum Dis; 2008 Jun; 67(6):867-72. PubMed ID: 17823201
[TBL] [Abstract][Full Text] [Related]
5. Effect of CD40-CD40 ligand interaction on diacylglycerol-protein kinase C signal transduction pathway and intracellular calcium in cultured human monocytes.
Yan JC; Wu ZG; Kong XT; Zong RQ; Zhang LZ
Acta Pharmacol Sin; 2003 Jul; 24(7):687-91. PubMed ID: 12852836
[TBL] [Abstract][Full Text] [Related]
6. FK506 and anti-CD40 ligand in peripheral nerve allotransplantation.
Brenner MJ; Mackinnon SE; Rickman SR; Jaramillo A; Tung TH; Hunter DA; Mohanakumar T
Restor Neurol Neurosci; 2005; 23(3-4):237-49. PubMed ID: 16082080
[TBL] [Abstract][Full Text] [Related]
7. The road to tolerance: renal transplant tolerance induction in nonhuman primate studies and clinical trials.
Elster EA; Hale DA; Mannon RB; Cendales LC; Swanson SJ; Kirk AD
Transpl Immunol; 2004; 13(2):87-99. PubMed ID: 15380539
[TBL] [Abstract][Full Text] [Related]
8. The multi-functionality of CD40L and its receptor CD40 in atherosclerosis.
Lievens D; Eijgelaar WJ; Biessen EA; Daemen MJ; Lutgens E
Thromb Haemost; 2009 Aug; 102(2):206-14. PubMed ID: 19652870
[TBL] [Abstract][Full Text] [Related]
9. Novel insights into anti-CD40/CD154 immunotherapy in transplant tolerance.
Pinelli DF; Ford ML
Immunotherapy; 2015; 7(4):399-410. PubMed ID: 25917630
[TBL] [Abstract][Full Text] [Related]
10. New possibilities of therapeutic interventions in transplantation.
Magott-Procelewska M; Klinger M
Ann Transplant; 2004; 9(3):19-24. PubMed ID: 15759542
[TBL] [Abstract][Full Text] [Related]
11. CD40/CD40L interaction induces Abeta production and increases gamma-secretase activity independently of tumor necrosis factor receptor associated factor (TRAF) signaling.
Volmar CH; Ait-Ghezala G; Frieling J; Weeks OI; Mullan MJ
Exp Cell Res; 2009 Aug; 315(13):2265-74. PubMed ID: 19422822
[TBL] [Abstract][Full Text] [Related]
12. Platelet pro-aggregatory effects of CD40L monoclonal antibody.
Mirabet M; Barrabés JA; Quiroga A; Garcia-Dorado D
Mol Immunol; 2008 Feb; 45(4):937-44. PubMed ID: 17959249
[TBL] [Abstract][Full Text] [Related]
13. The immunobiology of CD154-CD40-TRAF interactions in atherosclerosis.
Engel D; Seijkens T; Poggi M; Sanati M; Thevissen L; Beckers L; Wijnands E; Lievens D; Lutgens E
Semin Immunol; 2009 Oct; 21(5):308-12. PubMed ID: 19616449
[TBL] [Abstract][Full Text] [Related]
14. A novel fully human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys.
Imai A; Suzuki T; Sugitani A; Itoh T; Ueki S; Aoyagi T; Yamashita K; Taniguchi M; Takahashi N; Miura T; Shimamura T; Furukawa H; Todo S
Transplantation; 2007 Oct; 84(8):1020-8. PubMed ID: 17989608
[TBL] [Abstract][Full Text] [Related]
15. CD154 and its receptors in inflammatory vascular pathologies.
Hassan GS; Merhi Y; Mourad WM
Trends Immunol; 2009 Apr; 30(4):165-72. PubMed ID: 19282242
[TBL] [Abstract][Full Text] [Related]
16. CD40/CD40L dyad in the inflammatory and immune responses in the central nervous system.
Chen K; Huang J; Gong W; Zhang L; Yu P; Wang JM
Cell Mol Immunol; 2006 Jun; 3(3):163-9. PubMed ID: 16893496
[TBL] [Abstract][Full Text] [Related]
17. Molecular signature of mice T lymphocytes following tolerance induction by allogeneic BMT and CD40-CD40L costimulation blockade.
Perco P; Blaha P; Kainz A; Mayer B; Hauser P; Wekerle T; Oberbauer R
Transpl Int; 2006 Feb; 19(2):146-57. PubMed ID: 16441364
[TBL] [Abstract][Full Text] [Related]
18. Cooperativity in the interaction of synthetic CD40L mimetics with CD40 and its implication in cell signaling.
Wieckowski S; Trouche N; Chaloin O; Guichard G; Fournel S; Hoebeke J
Biochemistry; 2007 Mar; 46(11):3482-93. PubMed ID: 17319699
[TBL] [Abstract][Full Text] [Related]
19. Dehydroepiandrosterone inhibits CD40/CD40L expression on human umbilical vein endothelial cells induced by interferon gamma.
Li Y; Xia Z; Wang M
Int Immunopharmacol; 2009 Feb; 9(2):168-72. PubMed ID: 19015047
[TBL] [Abstract][Full Text] [Related]
20. CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular disease.
Rizvi M; Pathak D; Freedman JE; Chakrabarti S
Trends Mol Med; 2008 Dec; 14(12):530-8. PubMed ID: 18977174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
